Jake Weitzen

Jake Weitzen is a seasoned executive in the advertising and marketing sector, currently serving as SVP Group Account Director at Arnold Worldwide since August 2025. Prior to this role, Weitzen held senior positions at Humancare, leading DTC account strategies across multiple channels, and at 21GRAMS, overseeing key accounts for the hemophilia drug Hemlibra. With extensive experience at Grey Group, Weitzen was instrumental in launching the Olumiant brand and developing significant strategic initiatives for various pharmaceutical products, including Taltz and Opdivo. Weitzen began a career in account management at Publicis Kaplan Thaler, successfully managing global brand strategies for Hilton Worldwide and contributing to impactful campaigns for Doctors of the World. Weitzen holds a Bachelor of Arts in Economics from Tufts University.